Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C22H25NO3.ClH |
| Molecular Weight | 387.9 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C1OC(CCN2CCCCC2)OC1(C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=JXNQXJVDHXGEPU-UHFFFAOYSA-N
InChI=1S/C22H25NO3.ClH/c24-21-22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)26-20(25-21)14-17-23-15-8-3-9-16-23;/h1-2,4-7,10-13,20H,3,8-9,14-17H2;1H
Pipoxolan is an antispasmodic drug. In vivo, the drug inhibited the contractions of intestines caused by neostigmine, barium chloride or injection of acetylcholine. The drug possesses ganglioplegic action and inhibited the decrease in blood pressure caused by stimulation of the vagus nerve. The drug is marketed under tradename Rowapraxin worldwide for the treatment of spasms and colics in the gastrointestinal tract, gallbladder and urogenital area, bronchial spasms, spastic menstrual cramps. Recent studies have shown that pipoxalan has anticancer activity and inhibits proliferation of leukemia cells in animal models.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:1901080 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5440391 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID5057672
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
235861
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | RxNorm | ||
|
18174-58-8
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
28931
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
100000079705
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
VIA6WM647S
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
SUB14896MIG
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
C170323
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110645
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | |||
|
m8866
Created by
admin on Mon Mar 31 18:37:35 GMT 2025 , Edited by admin on Mon Mar 31 18:37:35 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY
SUBSTANCE RECORD